Proton-pump inhibitor use and the development of new ischemic heart disease in non-cardiac chest pain patients.

Yeseong D KimStephen GanocyRonnie Fass

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2020)

PPIs confer a statistically significant, but marginal effect on the risk of IHD development in NCCP patients. Thus, PPI use in NCCP only minimally alters the overall benign natural course of the disease.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes